Structural basis of the interaction between IgG and Fcγ receptors

Journal of Molecular Biology

Volumn 295, Issue 2, 2000, Pages 213-224

  Kato, Koichi ^a   Sautès Fridman, Catherine ^b   Yamada, Wakako ^a   Kobayashi, Kaoru ^c   Uchiyama, Susumu ^c   Kim, Hahyung ^a   Enokizono, Junichi ^a   Galinha, Annie ^b   Kobayashi, Yuji ^c   Fridman, Wolf Herman ^b   Arata, Yoji ^d   Shimada, Ichio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b INSERM   (France)

^c OSAKA UNIVERSITY   (Japan)

^d WATER RESEARCH INSTITUTE   (Japan)

Author keywords

Fc receptor; IgG; NMR; Ultracentrifugation

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2B; POLYPEPTIDE;

ANIMAL CELL; ARTICLE; BINDING SITE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL ACTIVATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CROSS LINKING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN FOLDING;

ANIMALIA;

EID: 0343185953     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3351     Document Type: Article

References (50)

1. Burmeister W. P., Huber A. H., Bjorkman P. J. Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature. 372:1994;379-383.
2. H2 domain and is modulated by the hinge region. J. Exp. Med. 173:1991;1483-1491.
3. γ receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies. Proc. Natl Acad. Sci. USA. 88:1991;9036-9040.
4. Clarkson S. B., Bussel J. B., Kimberly R. P., Valinsky J. E., Nachman R. L., Unkeless J. C. Treatment of refractory immune thrombocytopenic purpura with an anti-Fcγ-receptor antibody. N. Engl. J. Med. 314:1986;1236-1239.
5. Clynes R., Ravetch J. V. Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity. 3:1995;21-26.
6. Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-Å resolution. Biochemistry. 20:1981;2361-2370.
7. Diamond B., Boccumini L., Birshtein B. K. Site of binding of IgG2b and IgG2a by mouse macrophage Fc receptors by using cyanogen bromide fragments. J. Immunol. 134:1985;1080-1083.
8. Duncan A. R., Woof J. M., Partridge L. J., Burton D. R., Winter G. Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature. 332:1988;563-564.
9. Durchschlag H. Specific volumes of biological macromolecules and other molecules of biological interest. Hinz H.-J. Thermodynamic Data for Biochemistry and Biotechnology. 1986;45-128 Springer-Verlag, Berlin.
10. Fridman W. H., Bonnerot C., Daëron M., Amigorena S., Teillaud J. L., Sautès C. Structural bases of Fcγ receptor functions. Immunol. Rev. 125:1992;49-76.
11. Gavin A., Hulett M., Hogarth P. M. Molecular basis for the interaction of Fc receptors with immunoglobulins. van de Winkel J. G. J., Hogarth P. M. The Immunoglobulin Receptors and Their Physiological Roles in Immunity. 1998;11-35 Kluwer Academic Publishers.
12. Gergely J., Sarmay G. The two binding-site models of human IgG binding Fcγ receptors. FASEB J. 4:1990;3275-3283.
13. 1 and its low-affinity receptor FcγRIII. Biochemistry. 34:1995;13320-13327.
14. γRII. Biochemistry. 36:1997;952-959.
15. Gouda H., Torigoe H., Saito A., Sato M., Arata Y., Shimada I. Three-dimensional solution structure of the B domain of staphylococcal protein A: comparisons of the solution and crystal structures. Biochemistry. 31:1992;9665-9672.
16. Greenwood J., Clark M., Waldmann H. Structural motifs involved in human IgG antibody effector functions. Eur. J. Immunol. 23:1993;1098-1104.
17. Harris L. J., Larson S. B., Hasel K. W., McPherson A. Refined structure of an intact IgG2a monoclonal antibody. Biochemistry. 36:1997;1581-1597.
18. Hazenbos W. L. W., Gessner J. E., Hofhuis F. M. A., Kuipers H., Meyer D., Heijnen I. A. F. M., Schmidt R. E., Sandor M., Capel P. J. A., Daëron M., van de Winkel J. G. J., Verbeek J. S. Impaired IgG-dependent anaphylaxis and arthus reaction in FcγRIII (CD16) deficient mice. Immunity. 5:1996;181-188.
19. Hindley S. A., Gao Y., Nash P. H., Sautes C., Lund J., Goodall M., Jefferis R. The interaction of IgG with FcγRII: involvment of the lower hinge binding site as probed by NMR. Biochem. Soc. Trans. 21:1993;337S.
20. Hsieh H. V., Thompson N. L. Dissociation kinetics between a mouse Fc receptor (FcγRII) and IgG: measurement by total internal reflection with fluorescence photobleaching recovery. Biochemistry. 34:1995;12481-12488.
21. Huber A. H., Kelley R. F., Gastinel L. N., Bjorkman P. J. Crystallization and stoichiometry of binding of a complex between a rat intestinal Fc receptor and Fc. J. Mol. Biol. 230:1993;1077-1083.
22. Kainosho M., Tsuji T. Assignment of the three methionyl carbonyl carbon resonances in Streptomyces subtilisin inhibitor by a carbon-13 and nitrogen-15 double-labeling technique. A new strategy for structural studies of proteins in solution. Biochemistry. 21:1982;6273-6279.
23. Kanellopoulos J. M., Liu T.-Y., Poy G., Metzger H. Composition and subunit structure of the cell receptor for immunoglobulin E. J. Biol. Chem. 255:1980;9060-9066.
24. 13C nuclear magnetic resonance spectroscopy to molecular structural analyses of antibody molecules. J. Biochem. 105:1989;867-869.
25. 13C]methionine. Biochemistry. 30:1991a;270-278.
26. Kato K., Matsunaga C., Odaka A., Yamato S., Takaha W., Shimada I., Arata Y. Carbon-13 NMR study of switch variant anti-dansyl antibodies: antigen binding and domain-domain interactions. Biochemistry. 30:1991b;6604-6610.
27. 13C NMR study of the mode of interaction in solution of the B fragment of staphylococcal protein A and the Fc fragments of mouse immunoglobulin G. FEBS Letters. 328:1993;49-54.
28. Kato K., Lian L.-Y., Barsukov I. L., Derrick J. P., Kim H., Tanaka R., Yoshino A., Shiraishi M., Shimada I., Arata Y., Roberts G. C. K. Model for the complex between protein G and an antibody Fc fragment in solution. Structure. 3:1995;79-85.
29. Keown M. B., Ghirlando R., Young R. J., Beavil A. J., Owens R. J., Perkins S. J., Sutton B. J., Gould H. J. Hydrodynamic studies of a complex between the Fc fragment of human IgE and a soluble fragment of the FcεRI α chain. Proc. Natl Acad. Sci. USA. 92:1995;1841-1845.
30. Keown M. B., Ghirlando R., Mackay G. A., Sutton B. J., Gould H. J. Basis of the 1:1 stoichiometry of the high affinity receptor FcεRI-IgE complex. Eur. Biophys. J. 25:1997;471-476.
31. Koolwijk P., Spierenburg G. T., Frasa H., Boot J. H. A., van de Winkel J. G. J., Bast B. J. E. G. Interaction between hybrid mouse monoclonal antibodies and the human high-affinity IgG FcR, huFcγRI, on U937. Involvement of only one of the mIgG heavy chains in receptor binding. J. Immunol. 143:1989;1656-1662.
32. Lund J., Tanaka T., Takahashi N., Sarmay G., Arata Y., Jefferis R. A protein structural change in aglycosylated IgG3 correlates with loss of huFcγR1 and huFcγR111 binding and/or activation. Mol. Immunol. 27:1990;1145-1153.
33. Lund J., Winter G., Jones P. T., Pound J. D., Tanaka T., Walker M. R., Artymiuk P. J., Arata Y., Burton D. R., Jefferis R., Woof J. M. Human FcγRI and FcγRII interact with distinct but overlapping sites on human IgG. J. Immunol. 147:1991;2657-2662.
34. H2 domain of IgG for mouse FcγRII. Mol. Immunol. 29:1992;53-59.
35. Matsuda H., Nakamura S., Ichikawa Y., Kozai K., Takano R., Nose M., Endo S., Nishimura Y., Arata Y. Proton nuclear magnetic resonance studies of the structure of the Fc fragment of human immunoglobulin G1: comparisons of native and recombinant proteins. Mol. Immunol. 27:1990;571-579.
36. Maxwell K. F., Powell M. S., Hulett M. D., Barton P. A., McKenzie I. F. C., Garrett T. P. J., Hogarth P. M. Crystal strucuture of the human leukocyte receptor FcγRIIa. Nature Struct. Biol. 6:1999;437-442.
37. Metzger H. The effect of antigen on antibodies: recent studies. Contemp. Top. Mol. Immunol. 7:1978;119-152.
38. H2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, FcγRI and FcγRIII binding. Immunology. 86:1995;319-324.
39. Sarmay G., Lund J., Rozsnyay Z., Gergely J., Jefferis R. Mapping and comparison of the interaction sites on the Fc region of IgG responsible for triggering antibody dependent cellular cytotoxicity (ADCC) through different types of human Fcγ receptor. Mol. Immunol. 29:1992;633-639.
40. Sauer-Eriksson A. E., Kleywegt G. J., Uhlén M., Jones T. A. Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG. Structure. 3:1995;265-278.
41. Sautès C., Varin N., Teillaud C., Daëron M., Even J., Hogarth P. M., Fridman W. H. Soluble low affinity type II Fcγ receptors (IgG-binding factors) are generated by cleavage of membrane FcγRII. Eur. J. Immunol. 21:1991;231-234.
42. Sautès C., Galinha A., Bouchard C., Mazières N., Spagnoli R., Fridman W. H. Recombinant soluble Fcγ receptors: production, purification and biological activities. J. Chromatog. sect. B. 662:1994;197-207.
43. Sawada J., Terao T., Itoh S., Maeda M., Tsuji A., Hosoda H., Nambara T. Production and characterization of monoclonal antibodies to 17α-hydroxyprogesterone. J. Steroid Biochem. 28:1987;405-410.
44. Sechi S., Roller P. P., Willette-Brown J., Kinet J. P. A conformational rearrangement upon binding of IgE to its high affinity receptor. J. Biol. Chem. 271:1996;19256-19263.
45. Sondermann P., Huber R., Jacob U. Crystal structure of the soluble form of the human Fcγ-receptor IIb: a new member of the immunoglobulin superfamily at 1.7 Å resolution. EMBO J. 18:1999a;1095-1103.
46. Sondermann P., Jacob U., Kutscher C., Frey J. Characterization and crystallization of soluble human Fcγ receptor II (CD32) isoforms produced in insect cells. Biochemistry. 38:1999b;8469-8477.
47. Stafford W. F. III. Boundary analysis in sedimentation transport experiments: a procedure for obtaining sedimentation coefficient distributions using the time derivative of the concentration profile. Anal. Biochem. 203:1992;295-301.
48. Teillaud J. L., Bouchard C., Astier A., Teillaud C., Tartour E., Michon J., Galinha A., Moncuit J., Mazières N., Spagnoli R., Fridman W. H., Sautès C. Natural and recombinant soluble low-affinity FcγR: detection, purification, and functional activities. Immunomethods. 4:1994;48-64.
49. Varin N., Sautès C., Galinha A., Even J., Hogarth P. M., Fridman W. H. Recombinant soluble receptors for the Fcγ portion inhibit antibody production in vitro. Eur. J. Immunol. 19:1989;2263-2268.
50. Yamaguchi Y., Kim H., Kato K., Masuda K., Shimada I., Arata Y. Proteolytic fragmentation with high specificity of mouse immunoglobulin G. Mapping of proteolytic cleavage sites in the hinge region. J. Immunol. Methods. 181:1995;259-267.